Cargando…

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)

BACKGROUND: The RV3-BB human neonatal rotavirus vaccine was developed to provide protection from severe rotavirus disease from birth. The aim of this study was to investigate the potential for mutual interference in the immunogenicity of oral polio vaccine (OPV) and RV3-BB. METHODS: A randomized, pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cowley, Daniel, Sari, Rini Mulia, Handley, Amanda, Watts, Emma, Bachtiar, Novilia S., At Thobari, Jarir, Satria, Cahya Dewi, Bogdanovic-Sakran, Nada, Nirwati, Hera, Orsini, Francesca, Lee, Katherine J., Kirkwood, Carl D., Soenarto, Yati, Bines, Julie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880301/ https://www.ncbi.nlm.nih.gov/pubmed/31607604 http://dx.doi.org/10.1016/j.vaccine.2019.09.071

Ejemplares similares

Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth
por: Bines, Julie E., et al.
Publicado: (2018)

Antimicrobial use in an Indonesian community cohort 0-18 months of age
por: At Thobari, Jarir, et al.
Publicado: (2019)

Non-antibiotic medication use in an Indonesian community cohort 0–18 months of age
por: At Thobari, Jarir, et al.
Publicado: (2020)

Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia
por: Cowley, Daniel, et al.
Publicado: (2018)

Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine
por: Cowley, Daniel, et al.
Publicado: (2018)

Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status
por: Boniface, Karen, et al.
Publicado: (2020)

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
por: Geard, Nicholas, et al.
Publicado: (2022)

Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey
por: At Thobari, Jarir, et al.
Publicado: (2021)

Detection of group A rotavirus strains circulating among children with acute diarrhea in Indonesia
por: Nirwati, Hera, et al.
Publicado: (2016)

The prevalence and determinants of vitamin D deficiency in Indonesian infants at birth and six months of age
por: Oktaria, Vicka, et al.
Publicado: (2020)

Nutritional status, exclusive breastfeeding and management of acute respiratory illness and diarrhea in the first 6 months of life in infants from two regions of Indonesia
por: Oktaria, V., et al.
Publicado: (2017)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study
por: Witte, Desiree, et al.
Publicado: (2022)

Religious and community leaders’ acceptance of rotavirus vaccine introduction in Yogyakarta, Indonesia: a qualitative study
por: Padmawati, Retna Siwi, et al.
Publicado: (2019)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Knowledge and attitudes towards rotavirus diarrhea and the vaccine amongst healthcare providers in Yogyakarta Indonesia
por: Seale, Holly, et al.
Publicado: (2015)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia
por: Nency, Yetty M., et al.
Publicado: (2022)

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule
por: Rusmil, Kusnandi, et al.
Publicado: (2015)

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report
por: Medise, Bernie Endyarni, et al.
Publicado: (2020)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine
por: Medise, Bernie Endyarni, et al.
Publicado: (2019)

The Case for Live Poliovirus Vaccination
por: Paul, John R.
Publicado: (1960)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
por: Marin, Mona, et al.
Publicado: (2017)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia
por: Koesnoe, Sukamto, et al.
Publicado: (2021)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Recombinant Vaccine–Derived Poliovirus in Madagascar
por: Rousset, Dominique, et al.
Publicado: (2003)

Vaccine–derived Poliovirus, Thailand, 2003
por: Tharmaphornpilas, Piyanit
Publicado: (2005)

Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013–2016
Publicado: (2015)

Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization
por: Sarnquist, Clea, et al.
Publicado: (2018)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Plant-made poliovirus vaccines – Safe alternatives for global vaccination
por: Bolaños-Martínez, Omayra C., et al.
Publicado: (2022)

Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
por: DUINTJER TEBBENS, R. J., et al.
Publicado: (2017)

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
por: Gunardi, Hartono, et al.
Publicado: (2018)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_34nlck3q00pqs1d4j8t5v2itnr